Uracil DNA glycosylase disruption blocks Ig gene conversion and induces transition mutations

Journal of Immunology

Volumn 176, Issue 1, 2006, Pages 365-371

  Saribasak, Huseyin ^a   Saribasak, Nesibe Nur ^a   Ipek, Fatih M ^a   Ellwart, Joachim W ^a   Arakawa, Hiroshi ^a   Buerstedde, Jean Marie ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; CYTIDINE DEAMINASE; CYTOSINE; IMMUNOGLOBULIN; UNCLASSIFIED DRUG; URACIL; URACIL DNA GLYCOSYLTRANSFERASE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CHICKEN; ENZYME ACTIVITY; ENZYME INACTIVATION; GENE CONVERSION; GENE DELETION; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; IMMUNOGLOBULIN GENE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SEQUENCE ANALYSIS;

EID: 29644440411     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.1.365     Document Type: Article

References (15)

1. Muramatsu, M., K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563.
2. Revy, P., T. Muto, Y. Levy, F. Geissmann, A. Plebani, O. Sanal, N. Catalan, M. Forveille, R. Dufourcq-Labelouse, A. Gennery, et al. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 102: 565-575.
3. Arakawa, H., J. Hauschild, and J. M. Buerstedde. 2002. Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion. Science 295: 1301-1306.
4. Harris, R. S., J. E. Sale, S. K. Petersen-Mahrt, and M. S. Neuberger. 2002. AID is essential for immunoglobulin V gene conversion in a cultured B cell line. Curr. Biol. 12: 435-438.
5. Rada, C., G. T. Williams, H. Nilsen, D. E. Barnes, T. Lindahl, and M. S. Neuberger. 2002. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 12: 1748-1755.
6. Imai, K., G. Slupphaug, W. I. Lee, P. Revy, S. Nonoyama, N. Catalan, L. Yel, M. Forveille, B. Kavli, H. E. Krokan, et al. 2003. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat. Immunol. 4: 1023-1028.
7. Arakawa, H., and J. M. Buerstedde. 2004. Immunoglobulin gene conversion: Insights from bursal B cells and the DT40 cell line. Dev. Dyn. 229: 458-464.
8. Sale, J. E., D. M. Calandrini, M. Takata, S. Takeda, and M. S. Neuberger. 2001. Ablation of XRCC2/3 transforms immunoglobulin V gene conversion into somatic hypermutation. Nature 412: 921-926.
9. Arakawa, H., H. Saribasak, and J. M. Buerstedde. 2004. Activation-induced cytidine deaminase initiates immunoglobulin gene conversion and hypermutation by a common intermediate. PLoS Biol. 2: 967-974.
10. Di Noia, J. M., and M. S. Neuberger. 2002. Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 419: 43-48.
11. Di Noia, J. M., and M. S. Neuberger. 2004. Immunoglobulin gene conversion in chicken DT40 cells largely proceeds through an abasic site intermediate generated by excision of the uracil produced by AID-mediated deoxycytidine deamination. Eur. J. Immunol. 34: 504-508.
12. Ahdrakhmanov. I., D. Lodygin, P. Geroth, H. Arakawa, A. Law, J. Plachy, B. Korn, and J. M. Buerstedde. 2000. A large database of chicken bursal ESTs as a resource for the analysis of vertebrate gene function. Genome Res. 10: 2062-2069.
13. International Chicken Genome Sequencing Consortium. 2004. Sequence and comparative analysis of the chicken genome provide unique perspectives on vertebrate evolution. Nature 432: 695-716.
14. Arakawa, H., D. Lodygin, and J. M. Buerstedde. 2001. Mutant loxP vectors for selectable marker recycle and conditional knock-outs. BMC Biotechnol. 1: 7.
15. Rada, C., J. M. Di Noia, and M. S. Neuberger. 2004. Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation. Mol. Cell 16: 163-171.